Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation

<b>Background</b>: Therapeutic/intermediate-dose heparin reduces the risk of thromboembolic events but increases the risk of major bleeding in patients hospitalized for acute COVID-19 pneumonia. <b>Objectives</b>: To prospectively assess the incidence of objectively proven ve...

Full description

Saved in:
Bibliographic Details
Main Authors: Francesco Poletto, Luca Spiezia, Chiara Simion, Elena Campello, Fabio Dalla Valle, Daniela Tormene, Giuseppe Camporese, Paolo Simioni
Format: Artigo
Language:Inglês
Published: MDPI AG 2022-03-01
Series:Viruses
Subjects:
venous thromboembolism
COVID-19
prophylactic-dose anticoagulation
Online Access:https://www.mdpi.com/1999-4915/14/4/737
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items